James O'Brien

James O'Brien

Direttore Finanziario/CFO presso MESOBLAST LIMITED
59 anni
Health Technology
Commercial Services
Consumer Services

Profilo

James M.
O'Brien
is currently Chief Financial Officer at Mesoblast Ltd. since 2025.
Former positions include Chief Financial Officer at Faron Pharmaceuticals Oy from 2023 to 2024, Chief Financial Officer at Cognition Therapeutics, Inc. from 2019 to 2022, Executive Vice President-Finance at Enzo Biochem, Inc. from 2014 to 2019, Vice President & Corporate Controller at Allergan UC from 2010 to 2013, Vice President at Takeda Pharmaceutical Co., Ltd. in 2010, Chief Accounting Officer at U.S.I.
Holdings Corp.
from 2008 to 2009, Vice President & Controller at Aptuit LLC from 2005 to 2007, Chief Accountant at Purdue Pharma LP, and Principal at both Bristol Myers Squibb Co. and PricewaterhouseCoopers LLP.
Education includes undergraduate studies at George Washington University and an MBA from Fordham University.

Posizioni attive di James O'Brien

SocietàPosizioneInizio
MESOBLAST LIMITED Direttore Finanziario/CFO 17/11/2025

Precedenti posizioni note di James O'Brien

SocietàPosizioneFine
FARON PHARMACEUTICALS OY Direttore Finanziario/CFO 15/04/2024
COGNITION THERAPEUTICS, INC. Direttore Finanziario/CFO 12/08/2022
ENZO BIOCHEM, INC. Corporate Officer/Principal 03/11/2019
ALLERGAN PLC Comptroller/Controller/Auditor -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/08/2010
Vedi nel dettaglio l'esperienza di James O'Brien

Formazione di James O'Brien

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

28

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Health Technology

Consumer Services

Distribution Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. James O'Brien
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA